Cargando…

A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis

Three decades of animal studies have reproducibly shown that hypothermia is profoundly cerebroprotective during or after a central nervous system (CNS) insult. The success of hypothermia in preclinical acute brain injury has not only fostered continued interest in research on the classic secondary i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Travis C., Kochanek, Patrick M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434603/
https://www.ncbi.nlm.nih.gov/pubmed/30802174
http://dx.doi.org/10.1089/ther.2019.0001
_version_ 1783406504844460032
author Jackson, Travis C.
Kochanek, Patrick M.
author_facet Jackson, Travis C.
Kochanek, Patrick M.
author_sort Jackson, Travis C.
collection PubMed
description Three decades of animal studies have reproducibly shown that hypothermia is profoundly cerebroprotective during or after a central nervous system (CNS) insult. The success of hypothermia in preclinical acute brain injury has not only fostered continued interest in research on the classic secondary injury mechanisms that are prevented or blunted by hypothermia but has also sparked a surge of new interest in elucidating beneficial signaling molecules that are increased by cooling. Ironically, while research into cold-induced neuroprotection is enjoying newfound interest in chronic neurodegenerative disease, conversely, the scope of the utility of therapeutic hypothermia (TH) across the field of acute brain injury is somewhat controversial and remains to be fully defined. This has led to the era of Targeted Temperature Management, which emphasizes a wider range of temperatures (33–36°C) showing benefit in acute brain injury. In this comprehensive review, we focus on our current understandings of the novel neuroprotective mechanisms activated by TH, and discuss the critical importance of developmental age germane to its clinical efficacy. We review emerging data on four cold stress hormones and three cold shock proteins that have generated new interest in hypothermia in the field of CNS injury, to create a framework for new frontiers in TH research. We make the case that further elucidation of novel cold responsive pathways might lead to major breakthroughs in the treatment of acute brain injury, chronic neurological diseases, and have broad potential implications for medicines of the distant future, including scenarios such as the prevention of adverse effects of long-duration spaceflight, among others. Finally, we introduce several new phrases that readily summarize the essence of the major concepts outlined by this review—namely, Ultramild Hypothermia, the “Responsivity of Cold Stress Pathways,” and “Hypothermia in a Syringe.”
format Online
Article
Text
id pubmed-6434603
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-64346032019-03-26 A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis Jackson, Travis C. Kochanek, Patrick M. Ther Hypothermia Temp Manag Review Three decades of animal studies have reproducibly shown that hypothermia is profoundly cerebroprotective during or after a central nervous system (CNS) insult. The success of hypothermia in preclinical acute brain injury has not only fostered continued interest in research on the classic secondary injury mechanisms that are prevented or blunted by hypothermia but has also sparked a surge of new interest in elucidating beneficial signaling molecules that are increased by cooling. Ironically, while research into cold-induced neuroprotection is enjoying newfound interest in chronic neurodegenerative disease, conversely, the scope of the utility of therapeutic hypothermia (TH) across the field of acute brain injury is somewhat controversial and remains to be fully defined. This has led to the era of Targeted Temperature Management, which emphasizes a wider range of temperatures (33–36°C) showing benefit in acute brain injury. In this comprehensive review, we focus on our current understandings of the novel neuroprotective mechanisms activated by TH, and discuss the critical importance of developmental age germane to its clinical efficacy. We review emerging data on four cold stress hormones and three cold shock proteins that have generated new interest in hypothermia in the field of CNS injury, to create a framework for new frontiers in TH research. We make the case that further elucidation of novel cold responsive pathways might lead to major breakthroughs in the treatment of acute brain injury, chronic neurological diseases, and have broad potential implications for medicines of the distant future, including scenarios such as the prevention of adverse effects of long-duration spaceflight, among others. Finally, we introduce several new phrases that readily summarize the essence of the major concepts outlined by this review—namely, Ultramild Hypothermia, the “Responsivity of Cold Stress Pathways,” and “Hypothermia in a Syringe.” Mary Ann Liebert, Inc., publishers 2019-03-01 2019-03-06 /pmc/articles/PMC6434603/ /pubmed/30802174 http://dx.doi.org/10.1089/ther.2019.0001 Text en © Travis C. Jackson and Patrick M. Kochanek, 2019; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Jackson, Travis C.
Kochanek, Patrick M.
A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis
title A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis
title_full A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis
title_fullStr A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis
title_full_unstemmed A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis
title_short A New Vision for Therapeutic Hypothermia in the Era of Targeted Temperature Management: A Speculative Synthesis
title_sort new vision for therapeutic hypothermia in the era of targeted temperature management: a speculative synthesis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434603/
https://www.ncbi.nlm.nih.gov/pubmed/30802174
http://dx.doi.org/10.1089/ther.2019.0001
work_keys_str_mv AT jacksontravisc anewvisionfortherapeutichypothermiaintheeraoftargetedtemperaturemanagementaspeculativesynthesis
AT kochanekpatrickm anewvisionfortherapeutichypothermiaintheeraoftargetedtemperaturemanagementaspeculativesynthesis
AT jacksontravisc newvisionfortherapeutichypothermiaintheeraoftargetedtemperaturemanagementaspeculativesynthesis
AT kochanekpatrickm newvisionfortherapeutichypothermiaintheeraoftargetedtemperaturemanagementaspeculativesynthesis